Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GFAP

GFAP

Brief Information

Name:Glial fibrillary acidic protein
Target Synonym:Glial Fibrillary Acidic Protein,Intermediate Filament Protein,ALXDRD,FLJ45472
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GFP-S453 Rabbit Polyclonal GFAP Antibody, Rabbit IgG
GFP-H5143 Human Human GFAP Protein, His Tag
GFP-H5143-structure
GFP-H5143-sds
GFP-M5148 Mouse Mouse GFAP Protein, His Tag
GFP-M5148-structure
GFP-M5148-sds
ACRO Quality

Part of Bioactivity data

GFP-M5148-ELISA
 GFAP ELISA

Immobilized Mouse GFAP, His Tag (Cat. No. GFP-M5148) at 1 μg/mL (100 μL/well) can bind GFAP Monoclonal Antibody with a linear range of 0.4-25 ng/mL (Routinely tested).

GFP-H5143-ELISA
 GFAP ELISA

Immobilized Human GFAP, His Tag (Cat. No. GFP-H5143) at 1 μg/mL (100 μL/well) can bind GFAP Monoclonal Antibody with a linear range of 0.8-25 ng/mL (QC tested).

Synonym Name

Glial fibrillary acidic protein

Background

GFAP (Glial fibrillary acidic protein) is a monomeric intermediate filament protein fuond in mature astrocytes and other glial cells but is not found outside the CNS. Increased GFAP immunoreactivity (or astrocytic activation) is usually viewed as an index of gliosis or a relatively slow-developing correlate of neural damage.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Gastrodine Approved Kpc Pharmaceuticals Inc 辛基宁, 天眩清, 曲络彤, 丹彤 Mainland China Vertigo; Brain Injuries, Traumatic; Headache; Neurasthenia Kpc Pharmaceuticals Inc 2001-01-01 Headache; Vertigo; Brain Injuries, Traumatic; Neurasthenia Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
ION-373 ION-373 Phase 3 Clinical Ionis Pharmaceuticals Inc Alexander Disease Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message